相似文献
1
SARS-CoV-2, from its current highly contagious spreading toward the global development of an effective and safe vaccine: challenges and uncertainties.
Expert Opin Drug Saf. 2020 Jul;19(7):771-774. doi: 10.1080/14740338.2020.1773789. Epub 2020 Jun 8.
2
Keeping track of the SARS-CoV-2 vaccine pipeline.
Nat Rev Immunol. 2020 Nov;20(11):650. doi: 10.1038/s41577-020-00455-1.
3
Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.
Vaccine. 2020 Nov 10;38(48):7588-7595. doi: 10.1016/j.vaccine.2020.10.034. Epub 2020 Oct 13.
4
COVID-19 Vaccine: A comprehensive status report.
Virus Res. 2020 Oct 15;288:198114. doi: 10.1016/j.virusres.2020.198114. Epub 2020 Aug 13.
5
COVID-19 vaccine trials: Duty of care and standard of prevention considerations.
Vaccine. 2020 Nov 10;38(48):7578-7580. doi: 10.1016/j.vaccine.2020.10.012. Epub 2020 Oct 9.
6
Developing Covid-19 Vaccines at Pandemic Speed.
N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.
7
Whither COVID-19 vaccines?
Nat Biotechnol. 2020 Oct;38(10):1132-1145. doi: 10.1038/s41587-020-0697-7.
8
News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.
Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8218-8221. doi: 10.1073/pnas.2005456117. Epub 2020 Mar 30.
9
Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.
J Microbiol Biotechnol. 2020 Aug 28;30(8):1109-1115. doi: 10.4014/jmb.2006.06006.
10
Immunological considerations for COVID-19 vaccine strategies.
Nat Rev Immunol. 2020 Oct;20(10):615-632. doi: 10.1038/s41577-020-00434-6. Epub 2020 Sep 4.
引用本文的文献
1
COVID-AMD database for coronavirus-infected animal models with comparative analysis tools.
Sci Rep. 2024 Nov 28;14(1):29567. doi: 10.1038/s41598-024-80474-3.
2
COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review.
3 Biotech. 2022 Jan;12(1):15. doi: 10.1007/s13205-021-03076-0. Epub 2021 Dec 12.
3
An overview of vaccine development for COVID-19.
Ther Deliv. 2021 Mar;12(3):235-244. doi: 10.4155/tde-2020-0129. Epub 2021 Feb 24.
4
COVID-19 in Light of Seasonal Respiratory Infections.
Biology (Basel). 2020 Aug 20;9(9):240. doi: 10.3390/biology9090240.
本文引用的文献
1
Vaccine safety issues at the turn of the 21st century.
BMJ Glob Health. 2021 May;6(Suppl 2). doi: 10.1136/bmjgh-2020-004898.
2
Developing Covid-19 Vaccines at Pandemic Speed.
N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.
3
[Genomic analysis of a 2019-novel coronavirus (2019-nCoV) strain in the first COVID-19 patient found in Hangzhou].
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 May 6;54(5):486-490. doi: 10.3760/cma.j.cn112150-20200217-00128.
4
Diversity among memory B cells: origin, consequences, and utility.
Science. 2013 Sep 13;341(6151):1205-11. doi: 10.1126/science.1241146.
5
LVIII. Besredka's method of vaccination.
J Hyg (Lond). 1912 Dec;12(Suppl):344-9.
6
Vaccination and its adverse effects: real or perceived. Society should think about means of linking exposure to potential long term effect.
BMJ. 1998 Jul 18;317(7152):159-60. doi: 10.1136/bmj.317.7152.159.
Zotero 插件